Pomalidomide-PEG3-C2-NH2 (also known as Cereblon Ligand-Linker Conjugates 5, E3 ligase Ligand-Linker Conjugates 30) is typically used as a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and 3-unit PEG linker for the synthesis of proteolysis-targeting chimera (PROTAC) technologies.
Discovery of MD-224 as a First-in-Class, Highly Potent, and Efficacious Proteolysis Targeting Chimera Murine Double Minute 2 Degrader Capable of Achieving Complete and Durable Tumor Regression. 
Development of a PDEδ-Targeting PROTACs that Impair Lipid Metabolism. 
 Y.Li, et al, J. Med. Chem., 2019, 62(2), pp 448-466.